All Legal articles – Page 5
View all stories with this category.
-
BusinessEuropean Commission to investigate excessive drug pricing
Inquiry covers claims that Aspen Pharma’s price rises on five cancer treatments were unjustified
-
Business
GE accused of exposing workers to toxic chemicals
Canadian union says dangerous compounds were used without proper worker protection
-
Business
Seattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
News
Legal battles stall US biosimilars
Unclear legislation and lack of regulatory guidance means companies are turning to the courts
-
Business
J&J fights talc cancer claims
Firm has lost several court cases linking talc to ovarian cancer, but vows to appeal
-
Business
India probes Roche over biosimilars
Mylan and Biocon claim Roche abused its market dominance to quash generic breast cancer antibodies
-
Business
Brexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
Business
US university sues Dow over pollution
Three hazardous chemicals have infiltrated campus groundwater, and the school wants Dow and others to pay for clean-up
-
Business
Lilly loses arbitration over Canadian patents
Firm had sought recompense under the Nafta trade agreement
-
Business
EU recommends withdrawing drugs approved on unreliable data
Indian firm Micro Therapeutic Research Labs accused of misrepresenting clinical data and documentation deficiencies
-
Business
PacBio sues Oxford Nanopore for patent infringement
Firms spar over single-molecule gene sequencing technology
-
Business
Crispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
Business
$2bn Immunomedics–Seattle Genetics deal delayed amid shareholder infighting
Major investor venBio seeks to derail deal and replace board members
-
Business
Merck & Co settles cancer antibody patent dispute
US firm will pay Bristol-Myers Squibb and Ono $625m plus royalties on future sales of immunotherapy
-
Business
Teva hit with fines and patent loss
Double whammy as firm settles subsidiary pay-for-delay suit and courts invalidate patents on multiple sclerosis drug
-
Business
US Supreme Court denies Dow tax appeal
Request to reconsider $1bn tax deduction dismissed and penalties upheld
-
News
Volkswagen hit by another $4.3bn in penalties
Emissions cheating scandal has led to the arrest of six senior employees at the company, just as Fiat comes under fire
-
Business
Cholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
Business
Shell fined $22m for drinking water contamination
Jury rules in favour of US city of Clovis over 1,2,3-trichloropropane contamination, while rejecting punitive damages
-
Business
Indian court revokes ban on combination drugs
Companies claim government failed to follow procedure in restricting risky medicines
